Alpine Partners VI »

Alnylam Pharmaceuticals shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2025-12-31 $820k 2.1k 397.65
2021-12-31 $1.1M 6.3k 169.56
2017-09-30 $871k 7.4k 117.54

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Rivian Automotive Com Cl A (RIVN)
Archer Aviation Com Cl A (ACHR)
Carvana Cl A (CVNA)
Super Micro Computer Note 3.500% 3/0
Ares Management Corporation Cl A Com Stk (ARES)
Strategy Cl A New (MSTR)
Cornerstone Total Rtrn Fd In (CRF)
Cornerstone Strategic Value (CLM)
Banco Bradesco S A Sp Adr Pfd New (BBD)
Brookfield Business Partners Unit Ltd L P (BBU)
Warner Bros Discovery Com Ser A (WBD)
Exact Sciences Corp Note 0.375% 3/1
Spotify Usa Note 3/1
Gossamer Bio Note 5.000% 6/0

View all positions for Alpine Partners VI

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals